Intensive glycemic control

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%

Among 1,288 adults aged 65+ with diabetes, 61.5% had HbA1c less than 7% and 54.9% of these were treated with insulin or sulfonylureas; among patients with very complex/poor health, 56.4% had HbA1c <7%

Effect: adverse; 61.5% had HbA1c <7%; among complex/poor health patients, 56.4% had HbA1c <7% and 37.9% had HbA1c <6.5%